ResearcherYamaguchi UniversityActive in the last 2 years
Yusaku Watanabe
Matched on ORCID iD 0000-0001-5201-3733; OpenAlex author ID A5029385535. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoadjuvant chemotherapy. Co-author DOI 10.1016/j.suronc.2025.102333↗
- Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers16142522↗
- [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. Co-author PMID 39948974↗
- Calreticulin is highly expressed in pancreatic cancer stem-like cells. Co-author DOI 10.1111/cas.13061↗
- A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population. Co-author DOI 10.3892/ijo.2014.2603↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshitaro Shindo · 5 shared papers, 2014–2026 · strength 0.72
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. PMID 39948974↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Hiroto Matsui · 4 shared papers, 2016–2026 · strength 0.68
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. PMID 39948974↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Tatsuya Ioka · 3 shared papers, 2024–2026 · strength 0.64
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. PMID 39948974↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Masao Nakajima · 3 shared papers, 2024–2026 · strength 0.64
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. PMID 39948974↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Hidenori Takahashi · 3 shared papers, 2024–2026 · strength 0.64
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper [A Case of Pancreatic Cancer with Concomitant Pancreatic Metastasis of Renal Cell Carcinoma]. PMID 39948974↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Ryouichi Tsunedomi · 4 shared papers, 2014–2026 · strength 0.52
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Paper Calreticulin is highly expressed in pancreatic cancer stem-like cells. DOI 10.1111/cas.13061↗
- Hiroaki Nagano · 3 shared papers, 2016–2026 · strength 0.49
- Paper Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoa… DOI 10.1016/j.suronc.2025.102333↗
- Paper Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. DOI 10.3390/cancers16142522↗
- Paper Calreticulin is highly expressed in pancreatic cancer stem-like cells. DOI 10.1111/cas.13061↗
- Hiroaki Nagano · 1 shared paper, 2024 · strength 0.20
- Akira Yakabe · 1 shared paper, 2024 · strength 0.20
- Masaaki Oka · 2 shared papers, 2014–2016 · strength 0.08
- Tomio Ueno · 1 shared paper, 2016 · strength 0.04
- Hidetoshi Eguchi · 1 shared paper, 2016 · strength 0.04
- Satoshi Matsukuma · 1 shared paper, 2016 · strength 0.04
- Nobuaki Suzuki · 1 shared paper, 2014 · strength 0.03
- Koji Tamada · 1 shared paper, 2014 · strength 0.03
- Hideyuki Saya · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.